Press Release

CD BIOPARTICLES LAUNCHES NEW LINE OF FUNCTIONAL POLYSTYRENE PARTICLES



CD Bioparticles has announced a wide range of new Functional Polystyrene Particles with various surface functional groups.

FOR IMMEDIATE RELEASE

01/12/2023

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced a wide range of new Functional Polystyrene Particles with various surface functional groups such as amino, carboxyl and hydroxyl groups for covalent coupling of proteins or other ligands. The new polystyrene particles can be applied in immunoassays, analytical chemistry, and bio-nano interactions research.

Polystyrene microspheres not only exhibit the general properties of polymer microspheres, such as good sphericity, large specific surface area, good surface activity, and uniform and controllable particle size, but also possess some unique characteristics, such as high rigidity, insolubility in common solvents, and non-easy biodegradability. In addition, the benzene ring of polystyrene microspheres has strong reactivity, which can carry out a series of functionalization reactions, so that the surface of the microspheres has a variety of active functional groups, and the properties of polystyrene are better exploited.

Polystyrene particles provide a flexible platform for diagnostic and bioseparation applications. There are several methods for attaching biological ligands to polystyrene particles, including adsorption onto plain polystyrene particles, covalent adsorption onto surface functionalized particles, and attachment of ligands of interest onto particles precoated with binding proteins (e.g., streptavidin, protein A, or protein G).

CD Bioparticles now offers multiple functional polystyrene particles with various surface functional groups, such as amino, carboxyl and hydroxyl groups for covalent coupling of proteins or other ligands. They can be designed with Acrylate surface and supplied in water, with Alkyl-OH surface coatings to significantly reduce the non-specific binding of proteins, with Amine groups on the surface and Amine PS/DVB Particles, and also functionalized with COOH groups on the surface and Carboxyl Porous PS/DVB Particles cross-linked with 0.5% DVB.

These new functionalized polystyrene particles can be used for a variety of applications, including organic synthesis, analytical chemistry, drug delivery materials, bioimaging, labeling, and immunoassays. They demonstrate excellent stability, high binding capacity and ultra-high specificity (low background) and have been extensively validated in academic and industrial scale immunoturbidimetric assays.

For example, the DiagPoly™ Amine Polystyrene Particles, 0.025 μm (Cat. No. DFO-L026) are functionalized with amine groups (NH2) on the surface for covalent attachment of proteins, peptides and nucleic acids. These particles can be utilized as standards or markers, in immunoassays (such as latex agglutination assays and solid phase enzyme immunoassays), or coated with proteins for use in research and diagnostic tests.

In addition to the carboxyl and amino functionalized particles, CD Bioparticles also offers larger functionalized particles and different surface chemicals such as epoxy, PEG, NHS, and cycloalkane click chemicals.

CD Bioparticles' Functional Polystyrene Particles are available in a variety of sizes and functional groups. For more information, please visit https://www.cd-bioparticles.com/products/functional-polystyrene-particles-320.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Tags:
Functional Polystyrene Particles  |  CD Bioparticles  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles
Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development
CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.